0% found this document useful (0 votes)
220 views

CASP RCT Checklist 2020

This document provides an 11 question checklist to help systematically appraise randomized controlled trials (RCTs). It addresses whether the basic study design is valid, if the study was methodologically sound, the results, and if the results can be applied locally. The checklist evaluates aspects like randomization, blinding, similarity of study groups, comprehensiveness of results reporting, and applicability to the user's population. Following the checklist allows appraising validity, methodology, results, and usefulness of RCT evidence for clinical practice.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
220 views

CASP RCT Checklist 2020

This document provides an 11 question checklist to help systematically appraise randomized controlled trials (RCTs). It addresses whether the basic study design is valid, if the study was methodologically sound, the results, and if the results can be applied locally. The checklist evaluates aspects like randomization, blinding, similarity of study groups, comprehensiveness of results reporting, and applicability to the user's population. Following the checklist allows appraising validity, methodology, results, and usefulness of RCT evidence for clinical practice.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 4

CASPRandomised Controlled Trial Standard Checklist:

11questionstohelpyou makesenseofarandomised controlled trial (RCT)


Main issues for consideration:Severalaspectsneed to beconsideredwhenappraisinga
randomised controlled trial:

Is thebasic studydesignvalid for a randomised controlled


trial?(SectionA)
Was the study methodologically sound? (Section B)
Whataretheresults? (Section C)
Willtheresultshelplocally? (Section D)

The 11 questionsin the checklist aredesigned to helpyou


thinkabouttheseaspectssystematically.

Howtousethisappraisaltool:Thefirstthreequestions(Section A) are screeningquestionsabout


the validity of the basic studydesignandcanbeanswered quickly. If,in light of your responses
to Section A,you think the study design is valid, continue to Section B to assess whether the
study was methodologically sound and ifitis worthcontinuingwiththe appraisal by answering
theremainingquestions in Sections C and D.

Record‘Yes’, ‘No’or‘Can’ttell’in response to thequestions.Promptsbelowall but one of the


questionshighlightthe issues it is important to consider.Recordthereasonsforyour answersin
the spaceprovided. As CASPchecklistsweredesignedto beusedaseducational/teachingtoolsina
workshopsetting,wedonot recommend using ascoringsystem.

About CASP Checklists:TheCASPRCT checklistwasoriginally basedonJAMA


Users’guidestothe medicalliterature1994(adaptedfromGuyattGH,SackettDLand Cook
DJ),andpilotedwith healthcarepractitioners. This version has been updated taking into account
the CONSORT 2010 guideline (http://www.consort-statement.org/consort-2010, accessed 16
September 2020).

Citation:CASP recommendsusing theHarvardstyle,i.e.,CriticalAppraisalSkills


Programme(2021).CASP(insertnameofchecklisti.e.Randomised Controlled Trial) Checklist.
[online]Availableat:insert URL.Accessed:insert dateaccessed.

©CASPthisworkislicensedundertheCreativeCommonsAttribution–Non-Commercial- ShareA
like.To viewacopy ofthislicence,visithttps://creativecommons.org/licenses/by-sa/4.0/

CriticalAppraisalSkillsProgramme(CASP)www.casp-uk.net Part of OAP Ltd


Study and citation:........................................................................................................................

Section A: Is the basic study design valid for a randomised controlled trial?

1. Did the study address a clearly focused Yes No Can’t tell


research question? 
CONSIDER:
 Was the study designed to assess the
outcomes of an intervention?
 Is the research question ‘focused’ in terms
of:
• Population studied
• Intervention given
• Comparator chosen
• Outcomes measured?

2. Was the assignment of participants to Yes No Can’t tell


interventions randomised? 
CONSIDER:
• How was randomisation carried out? Was
the method appropriate?
• Was randomisation sufficient to eliminate
systematic bias?
• Was the allocationsequence concealed
frominvestigators andparticipants?

3. Wereall participantswho Yes No Can’t tell


enteredthestudyaccountedfor at its 
conclusion?
CONSIDER:
• Were losses to follow-up and exclusions
after randomisation accounted for?
• Were participants analysed inthe study
groupsto whichtheywererandomised
(intention-to-treat analysis)?
• Was the study stopped early? If so,what
was the reason?

Section B: Was the study methodologically sound?

4. Yes No Can’t tell


 Were the participants ‘blind’ to
intervention they were given? 
 Were the investigators ‘blind’ to the 
intervention they were giving to
participants?
 Were the people assessing/analysing 
outcome/s ‘blinded’?

5. Were the study groups similar at the start of Yes No Can’t tell
the randomised controlled trial? 
CONSIDER:
 Were the baseline characteristics of
eachstudygroup (e.g. age, sex, socio-
economic group) clearly set out?
 Were there any differences between the
study groups that could affect the
outcome/s?

2
6. Apart from the experimental intervention, Yes No Can’t tell
did eachstudygroup receive the same level of 
care (that is, were they treated equally)?

CONSIDER:
 Was there a clearly defined study protocol?
 If any additional interventions were given
(e.g. tests or treatments), were they similar
between the study groups?
 Were the follow-up intervals the same for
each studygroup?

SectionC:Whataretheresults?

7. Were the effectsof intervention reported Yes No Can’t tell


comprehensively? 
CONSIDER:
• Was a power calculation undertaken?
• What outcomes weremeasured, and were
they clearly specified?
• How were the results expressed? For
binary outcomes, were relative and
absolute effects reported?
• Werethe results reported for each outcome
in each study group at each follow-up
interval?
• Was there any missing or incomplete
data?
• Was there differential drop-out between
the study groups that could affect the
results?
• Were potential sources of bias identified?
• Whichstatistical tests were used?
• Were p values reported?

8. Was the precision of the estimate of the Yes No Can’t tell


intervention or treatment effect reported? 
CONSIDER:
• Were confidence intervals (CIs) reported?

9. Do the benefits of the experimental Yes No Can’t tell


intervention outweigh the harms and costs? 
CONSIDER:
 What was the size of the intervention or
treatment effect?
 Were harms or unintended effects reported
for each study group?
 Was a cost-effectiveness analysis
undertaken? (Cost-effectiveness analysis
allows a comparison to be made between
different interventions used in the care of
the same condition or problem.)

3
SectionD:Willtheresults help locally?

10. Can the results be applied to your local Yes No Can’t tell
population/in your context? 
CONSIDER:
• Are the studyparticipants similar to the
people in your care?
• Would any differencesbetween your
population and the study participants
alterthe outcomes reported in the study?
• Are the outcomes important to your
population?
• Are there any outcomesyou would have
wanted information on that have not been
studied or reported?
• Are there any limitations of the study that
would affect your decision?

11. Would the experimental intervention Yes No Can’t tell


provide greater value to the people in your 
care than any of the existing interventions?

CONSIDER:
 What resources are needed to introduce
this intervention taking into account time,
finances, and skills development or
training needs?
 Are you able to disinvest resources in one
or more existing interventions in order to
be able to re-invest in the new
intervention?

APPRAISAL SUMMARY: Record key points from your critical appraisal in this box. What is your
conclusion about the paper?Would you use it to change your practice or to recommend changes to
care/interventions used by your organisation? Could you judiciously implement this intervention
without delay?

You might also like